the United States’s
genomics and precision medicine industry,
in focus.

Translating Biomarkers to Clinical Trials

18.2% of this theme group

Researchers highlight gaps in moving metabolic and disease biomarkers from discovery to patient trials.

Clinical trial (35) · MEDLINE (27) · Biomarker (29) · Disease (54)

Evolving Paradigms in Chronic Limb-threatening Ischemia: A Systematic Review of Current and Emerging Diagnostic and Therapeutic Approaches

A Practical Roadmap for Clinical Translation of Metabolic Biomarkers: A Review

Tumor Microenvironment and Immunotherapy Gaps

17.5% of this theme group

Papers point out unresolved challenges in targeting immune checkpoints and metabolic pathways in cancer.

Cancer (102) · Tumor microenvironment (30) · Breast cancer (25) · Immunotherapy (28)

Metabolic reprogramming and cancer progression

Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy

Interpretation of Genetic Variants

17.1% of this theme group

Authors flag difficulties in classifying and reporting gene‑level findings for disease risk.

Gene (54) · Genome (47) · Gene expression (14) · Genetic testing (22)

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test result

Widespread Regulatory Turnover Across Human Segmental Duplications

Inflammation‑Driven Disease Mechanisms

17.1% of this theme group

Studies emphasize incomplete understanding of immune and metabolic links to neuro‑ and cardiovascular disorders.

Disease (84) · Inflammation (26) · Pathogenesis (23) · Immune system (42)

Parkinson’s disease: etiopathogenesis and treatment

Immunometabolic Pathways in Cardiovascular Disease: Inflammation and Metabolic Dysfunction Beyond Traditional Risk Factors

Computational and Synthetic Biology Limits

12.0% of this theme group

Works note methodological bottlenecks in applying bio‑informatics and synthetic tools to clinical contexts.

Computational biology (45) · Synthetic biology (12) · Extracellular vesicles (12) · Regenerative medicine (10)

Clinical metagenomics

Epigenetics: Definition, Mechanisms and Clinical Perspective

Metabolic Disease Complexity

11.3% of this theme group

Researchers discuss intertwined obesity, insulin resistance, and inflammatory pathways that hinder treatment progress.

Diabetes mellitus (45) · Disease (75) · Obesity (21) · Insulin resistance (14)

Inflammatory mechanisms linking obesity and metabolic disease

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management

Microbiome Knowledge Gaps

6.9% of this theme group

Papers identify unknowns in gut flora dynamics and therapeutic modulation across health and disease.

Microbiome (66) · Gut microbiome (17) · Human microbiome (14) · Gut flora (18)

Microbiota in health and diseases

The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation

Cautious Optimism in Cancer Immunotherapy

19.2% of this theme group

Authors urge careful validation of combination strategies and genomic biomarkers before clinical rollout.

Cancer (26) · Breast cancer (16) · Transcriptome (10) · Tumor microenvironment (5)

[Strategic Combination Approaches in Cancer Immunotherapy].

Comparative analysis of potentially actionable genomic alterations in early-onset versus later-onset gastrointestinal cancers.

Drug Development and Clinical Trial Risks

18.4% of this theme group

Studies caution about translational hurdles and safety uncertainties for emerging therapeutics.

Drug (17) · Drug discovery (8) · Clinical trial (15) · Disease (16)

The therapeutic potential of resveratrol: a review of clinical trials

Lipoprotein(a)-lowering therapies: a promising future

Epigenetic and Protein Structure Uncertainties

17.0% of this theme group

Researchers warn that epigenetic markers and protein dynamics may not yet be reliable for diagnostics.

DNA methylation (7) · Antibody (6) · Protein structure (4) · Epigenetics (7)

Characterizing the Conformational Dynamics of an Intrinsically Disordered Localization Sequence

Epigenetic Markers of Response to Psychotherapy in Obsessive-Compulsive Disorder

Genome Editing in Non‑Human Systems

14.1% of this theme group

Papers caution against over‑extrapolating plant genome‑selection results to human medicine.

Gene (18) · Genetic testing (7) · Genome editing (6) · Genome (11)

Genomic Selection for Crop Improvement

Genomic selection in plant breeding: from theory to practice

Diabetes Therapeutic Evidence Gaps

13.9% of this theme group

Authors highlight limited long‑term data and variable outcomes for newer diabetes interventions.

Diabetes mellitus (12) · Type 2 diabetes (6) · Disease (15) · MEDLINE (11)

Dose-dependent effects of SGLT2 inhibitors on circadian blood pressure in hypertensive patients with diabetes: A systematic review and Bayes

Presenting non-insulin-based indices of insulin resistance relevant to pre-hypertension: A systematic review and meta-analysis

Sequencing Bias and Benchmarking Issues

11.5% of this theme group

Works stress the need for robust standards to address systematic errors in genomic data.

DNA sequencing (16) · Genome (18) · Computational biology (13) · Benchmark (6)

Characterizing and measuring bias in sequence data

Critical Assessment of Metagenome Interpretation—a benchmark of metagenomics software

Microbiome‑Cancer Association Uncertainty

5.9% of this theme group

Studies advise prudence when linking gut microbial changes to colorectal cancer risk.

Microbiome (15) · Gut flora (8) · Gut microbiome (5) · Metagenomics (5)

Long-term impacts of antibiotic exposure on the human intestinal microbiota

Human Gut Microbiome and Risk for Colorectal Cancer

Targeting Inflammation in Metabolic Disease

18.5% of this theme group

Research points to promising therapeutic avenues that modulate immune pathways in diabetes and related disorders.

Disease (325) · Inflammation (102) · Diabetes mellitus (53) · Immune system (108)

Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities

Molecular Mechanisms Underlying Atherosclerosis and Current Advances in Targeted Therapeutics

Genomic Insights for Disease and Drug Targets

17.3% of this theme group

Large‑scale association studies reveal tissue‑specific genes that can guide precision therapies.

Genome (394) · Gene (264) · Genomics (118) · Genome-wide association study (67)

Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types

The druggable genome and support for target identification and validation in drug development

Multi‑Omic Computational Workflows

15.8% of this theme group

Advances in proteomics and bio‑informatics enable integrated models of protein‑nucleic acid interactions.

Proteomics (97) · Proteome (69) · Computational biology (104) · Workflow (58)

Metabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome \n

Large-scale multi-omic biosequence transformers for modeling protein–nucleic acid interactions

Novel Antimicrobial Discovery Platforms

14.8% of this theme group

Innovative screening and microphysiological systems accelerate identification of new antibiotics and therapeutics.

Antimicrobial (35) · Epitope (41) · Drug discovery (66) · Antibiotics (31)

Bioactive Phytochemicals in Experimental Models of Multiple Sclerosis: Mechanisms, Efficacy, and Translational Potential

Lymphatics-on-a-chip microphysiological system: engineering lymphatic structure and function <i>in vitro</i>

Cancer Biomarkers and Immunotherapy Advances

14.4% of this theme group

Emerging microRNA signatures and modeling tools expand diagnostic and treatment options for solid tumors.

Cancer (250) · Breast cancer (94) · Immunotherapy (80) · Colorectal cancer (48)

MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer

Advancing Cancer Research Through Stochastic Modeling: Insights into Tumor Growth, Evolution, and Treatment Response

CRISPR‑Based Genome Editing Expansion

11.1% of this theme group

New CRISPR tools broaden capabilities for multiplexed editing and RNA targeting in therapeutic contexts.

CRISPR (114) · Genome editing (66) · Cas9 (43) · Gene (125)

Multiplex Genome Engineering Using CRISPR/Cas Systems

RNA editing with CRISPR-Cas13

Spatial Transcriptomics for Cellular Profiling

8.1% of this theme group

Techniques reconstruct coherent gene expression maps, enhancing disease modeling and target discovery.

Transcriptome (345) · Transcription factor (65) · Gene (125) · Gene expression (46)

Reconstructing biologically coherent cellular profiles from imaging-based spatial transcriptomics

Transcriptomic Correlation Identifies Cell Model Representatives for <i>MYCN</i> -Amplified Pediatric Neuroblastoma, Downstream Impact of Mo

San Diego

23.5% across the displayed hubs

11 companies hiring · $4.5B disclosed funding

Cambridge

18.7% across the displayed hubs

13 companies hiring · $6.4B disclosed funding

San Francisco

17.0% across the displayed hubs

14 companies hiring · $5.8B disclosed funding

New York City

13.4% across the displayed hubs

2 companies hiring · $949.8M disclosed funding

Boston

10.1% across the displayed hubs

5 companies hiring · $1.9B disclosed funding

Seattle

7.5% across the displayed hubs

3 companies hiring · $1.5B disclosed funding

Rockville

5.3% across the displayed hubs

1 companies hiring · $334.8M disclosed funding

Berkeley

4.5% across the displayed hubs

2 companies hiring · $1.3B disclosed funding